Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Lemonade, Inc. (LMND)

Lemonade Q2 revenue rises 79% to $294.4 million; net loss narrows to $43.4 million

Positive Impact 3 of 5 earnings Written later

Lemonade reported second-quarter 2026 results, with revenue up 79% to $294.4 million and gross profit up 76% to $113.2 million. Net loss was $43.4 million, or $0.56 per share, compared with $43.9 million, or $0.60 per share, a year earlier. The company also gave third-quarter and full-year 2026 guidance and said it still expects positive Adjusted EBITDA in the fourth quarter.

Key points

  • Revenue rose to $294.4 million from $164.1 million in Q2 2025; in force premium grew 32% to $1.43 billion
  • Net loss was $43.4 million ($0.56 per share) versus $43.9 million ($0.60 per share) in Q2 2025
  • Adjusted EBITDA loss narrowed to $18.7 million from $40.9 million; full-year 2026 Adjusted EBITDA loss guidance is $51 million to $47 million
  • Full-year 2026 revenue guidance is $1,214 million to $1,220 million; company expects Q4 2026 Adjusted EBITDA of about $8 million

The filing

CompanyLemonade, Inc. (LMND)
Form8-K, current report
Filed with the SECJul 28, 2026, 7:00 PM ET
Accession number0001691421-26-000047

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 28, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.